Metagil-GV2

Composition: Glimepiride 2 mg + Voglibose 0.2 mg + Metformin 500 mg SR

Long Description:
Metagil GV2 is a higher-strength triple combination of Glimepiride 2 mg, Voglibose 0.2 mg, and Metformin 500 mg. This formulation provides strong and comprehensive control of Type 2 Diabetes by improving insulin secretion, slowing carbohydrate absorption, and improving insulin sensitivity throughout the day. It is suitable for patients requiring more potent glucose-lowering action, especially those with high post-meal sugar levels.

Uses:

• Advanced control of Type 2 Diabetes

• Management of high postprandial sugar levels

• Reduction of HbA1c

• For patients needing stronger therapy beyond dual medications

Side Effects:

• Low blood sugar

• Bloating, gas, abdominal discomfort

• Mild nausea or diarrhea

• Dizziness, sweating

• Rare: lactic acidosis

Other Details:

• Take just before meals for best effect

• Regular monitoring of sugar advised

• Avoid alcohol

• Not suitable for patients with severe renal issues